Richard Slayman, 62, underwent the four-hour procedure on March 16 as a treatment for end-stage kidney disease. The pig kidney, provided by Cambridge, Mass.-based eGenesis, contained 69 genomic edits to improve its compatibility with humans.
The procedure marks a historical milestone in the field of xenotransplantation and could offer a potential solution to the global organ shortage, according to Massachusetts General.
“Our hope is that this transplant approach will offer a lifeline to millions of patients worldwide who are suffering from kidney failure,” Tatsuo Kawai, MD, PhD, director of Massachusetts General’s Legorreta Center for Clinical Transplant Tolerance, said in a news release.
Mr. Slayman is recovering well and expected to be discharged from the hospital soon, the hospital said.
Learn more here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
